Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts …
SP Gampenrieder, A Peer, C Weismann… - Breast Cancer …, 2019 - Springer
Background Patients with early breast cancer (EBC) achieving pathologic complete
response (pCR) after neoadjuvant chemotherapy (NACT) have a favorable prognosis …
response (pCR) after neoadjuvant chemotherapy (NACT) have a favorable prognosis …
Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast …
T Fukuda, R Horii, N Gomi, Y Miyagi, S Takahashi, Y Ito… - Springerplus, 2016 - Springer
A pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) is a signature
of favorable prognosis in breast cancer. The aim of this study was to assess the accuracy of …
of favorable prognosis in breast cancer. The aim of this study was to assess the accuracy of …
MRI does not predict pathologic complete response after neoadjuvant chemotherapy for breast cancer
SF Sener, RE Sargent, C Lee… - Journal of surgical …, 2019 - Wiley Online Library
Background This study assessed whether magnetic resonance imaging (MRI) could
accurately predict pathologic complete response (pCR) after neoadjuvant chemotherapy …
accurately predict pathologic complete response (pCR) after neoadjuvant chemotherapy …
Discrepancies between pathological tumor responses and estimations of complete response by magnetic resonance imaging after neoadjuvant chemotherapy differ …
M Namura, H Tsunoda, H Yagata, N Hayashi… - Clinical Breast …, 2018 - Elsevier
Introduction The influence of breast cancer (BC) subtype in discrepancies between
pathologic complete response (pCR) and complete response by magnetic resonance …
pathologic complete response (pCR) and complete response by magnetic resonance …
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer: Translational …
JF De Los Santos, A Cantor, KD Amos, A Forero… - Cancer, 2013 - Wiley Online Library
BACKGROUND: Increased pathologic complete response (pCR) rates observed with
neoadjuvant chemotherapy (NCT) for some subsets of patients with invasive breast cancer …
neoadjuvant chemotherapy (NCT) for some subsets of patients with invasive breast cancer …
Prediction of pathologic complete response on MRI in patients with breast cancer receiving neoadjuvant chemotherapy according to molecular subtypes
J Kim, BK Han, EY Ko, ES Ko, JS Choi, KW Park - European Radiology, 2022 - Springer
Objectives This study aimed to investigate the predictability of breast MRI for pathologic
complete response (pCR) by molecular subtype in patients with breast cancer receiving …
complete response (pCR) by molecular subtype in patients with breast cancer receiving …
[HTML][HTML] The diagnostic accuracy of magnetic resonance imaging in predicting pathologic complete response after neoadjuvant chemotherapy in patients with different …
X Zhang, D Wang, Z Liu, Z Wang, Q Li… - … Imaging in Medicine …, 2020 - ncbi.nlm.nih.gov
Background Patients treated with neoadjuvant chemotherapy (NAC) who achieve a
pathologic complete response (pCR) can be identified preoperatively and can potentially be …
pathologic complete response (pCR) can be identified preoperatively and can potentially be …
Pre-treatment MRI tumor features and post-treatment mammographic findings: may they contribute to refining the prediction of pathologic complete response in post …
Purpose Radiologic complete response (rCR) in breast cancer patients after neoadjuvant
chemotherapy (NAC) does not necessarily correlate with pathologic complete response …
chemotherapy (NAC) does not necessarily correlate with pathologic complete response …
Breast cancer phenotype influences MRI response evaluation after neoadjuvant chemotherapy
EMS Negrão, JA Souza, EF Marques… - European Journal of …, 2019 - Elsevier
Purpose To evaluate which factors may influence magnetic resonance imaging (MRI)
performance in the detection of pathologic complete response (pCR) after neoadjuvant …
performance in the detection of pathologic complete response (pCR) after neoadjuvant …
Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced MRI for assessing pathological complete response to neoadjuvant therapy in …
M Kaiyin, T Lingling, T Leilei, L Wenjia, J Bin - Breast Cancer Research …, 2023 - Springer
Objective Breast cancer patients receiving neoadjuvant therapy (NAT) are in need of a more
patient-friendly imaging modality such as contrast-enhanced mammography (CEM) for …
patient-friendly imaging modality such as contrast-enhanced mammography (CEM) for …
相关搜索
- breast cancer neoadjuvant chemotherapy
- complete response neoadjuvant chemotherapy
- mri in patients neoadjuvant chemotherapy
- breast cancer pathologic response
- breast cancer mri in patients
- diagnostic accuracy neoadjuvant chemotherapy
- breast cancer diagnostic accuracy
- meta analysis neoadjuvant therapy
- breast cancer meta analysis
- molecular subtypes neoadjuvant chemotherapy
- breast cancer molecular subtypes
- breast cancer neoadjuvant therapy
- tumor responses neoadjuvant chemotherapy